Through a cell-based biological screening, the benzocinnolinone derivative (±)-2c was identified as a promising STAT3 inhibitor. Since SAR studies on a series of compounds structurally related to (±)-2c (1c, 2a-p, 3c, 4c, 6) showed that the latter had the most significant inhibitory activity, we investigated in depth its essential structural features. In particular, enantiomeric separation was performed, and the absolute configuration of the stereoisomers was assigned by theoretical and crystallographic studies. The biological evaluation highlighted that (S)-(-)-2c is twice as potent as (R)-(+)-2c.

Synthesis, structure-activity relationships and stereochemical investigations on new tricyclic pyridazinone derivatives as potential STAT3 inhibitors / F. Meneghetti, D. Masciocchi, A. Gelain, F. Porta, A. Pedretti, G. Celentano, D. Barlocco, L. Legnani, L. Toma, B. Kwon, A. Asai, S. Villa. ((Intervento presentato al 7. convegno Nuove Prospettive in Chimica Farmaceutica tenutosi a Savigliano nel 2013.

Synthesis, structure-activity relationships and stereochemical investigations on new tricyclic pyridazinone derivatives as potential STAT3 inhibitors

F. Meneghetti;D. Masciocchi;A. Gelain;F. Porta;A. Pedretti;G. Celentano;D. Barlocco;S. Villa
2013

Abstract

Through a cell-based biological screening, the benzocinnolinone derivative (±)-2c was identified as a promising STAT3 inhibitor. Since SAR studies on a series of compounds structurally related to (±)-2c (1c, 2a-p, 3c, 4c, 6) showed that the latter had the most significant inhibitory activity, we investigated in depth its essential structural features. In particular, enantiomeric separation was performed, and the absolute configuration of the stereoisomers was assigned by theoretical and crystallographic studies. The biological evaluation highlighted that (S)-(-)-2c is twice as potent as (R)-(+)-2c.
2013
Settore CHIM/08 - Chimica Farmaceutica
Synthesis, structure-activity relationships and stereochemical investigations on new tricyclic pyridazinone derivatives as potential STAT3 inhibitors / F. Meneghetti, D. Masciocchi, A. Gelain, F. Porta, A. Pedretti, G. Celentano, D. Barlocco, L. Legnani, L. Toma, B. Kwon, A. Asai, S. Villa. ((Intervento presentato al 7. convegno Nuove Prospettive in Chimica Farmaceutica tenutosi a Savigliano nel 2013.
Conference Object
File in questo prodotto:
File Dimensione Formato  
NPCF7_Abstract_book.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 4.41 MB
Formato Adobe PDF
4.41 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/261638
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact